{"id":"https://openalex.org/W2334050643","doi":"https://doi.org/10.1021/mp500333v","title":"Impact of Polymers on the Crystallization and Phase Transition Kinetics of Amorphous Nifedipine during Dissolution in Aqueous Media","display_name":"Impact of Polymers on the Crystallization and Phase Transition Kinetics of Amorphous Nifedipine during Dissolution in Aqueous Media","publication_year":2014,"publication_date":"2014-09-03","ids":{"openalex":"https://openalex.org/W2334050643","doi":"https://doi.org/10.1021/mp500333v","mag":"2334050643","pmid":"https://pubmed.ncbi.nlm.nih.gov/25185035"},"language":"en","primary_location":{"id":"doi:10.1021/mp500333v","doi":"https://doi.org/10.1021/mp500333v","is_oa":false,"landing_page_url":"https://doi.org/10.1021/mp500333v","pdf_url":null,"source":{"id":"https://openalex.org/S204562082","display_name":"Molecular Pharmaceutics","issn_l":"1543-8384","issn":["1543-8384","1543-8392"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-c","doyens","jufo-2","ki-jl-1","medline","norway-1","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320006","host_organization_name":"American Chemical Society","host_organization_lineage":["https://openalex.org/P4310320006"],"host_organization_lineage_names":["American Chemical Society"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Molecular Pharmaceutics","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5085973599","display_name":"Shweta A. Raina","orcid":"https://orcid.org/0000-0002-6598-6400","observed_orcids":["https://orcid.org/0000-0002-6598-6400"]},"institutions":[{"id":"https://openalex.org/I219193219","display_name":"Purdue University West Lafayette","ror":"https://ror.org/02dqehb95","country_code":"US","type":"education","lineage":["https://openalex.org/I219193219"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Shweta A. Raina","raw_affiliation_strings":["Department\rof Industrial and Physical Pharmacy, College of Pharmacy, Purdue University, West Lafayette, Indiana 47907, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department\rof Industrial and Physical Pharmacy, College of Pharmacy, Purdue University, West Lafayette, Indiana 47907, United States","institution_ids":["https://openalex.org/I219193219"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5049713684","display_name":"David E. Alonzo","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I2948539688","display_name":"AbbVie (United States)","ror":"https://ror.org/02g5p4n58","country_code":"US","type":"company","lineage":["https://openalex.org/I2948539688"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"David E. Alonzo","raw_affiliation_strings":["Drug\rProduct Development, Research and Development, AbbVie Inc., North Chicago, Illinois 60064, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Drug\rProduct Development, Research and Development, AbbVie Inc., North Chicago, Illinois 60064, United States","institution_ids":["https://openalex.org/I2948539688"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5019910492","display_name":"Geoff G. Z. Zhang","orcid":"https://orcid.org/0000-0001-5527-2781","observed_orcids":["https://orcid.org/0000-0001-5527-2781"]},"institutions":[{"id":"https://openalex.org/I2948539688","display_name":"AbbVie (United States)","ror":"https://ror.org/02g5p4n58","country_code":"US","type":"company","lineage":["https://openalex.org/I2948539688"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Geoff G. Z. Zhang","raw_affiliation_strings":["Drug\rProduct Development, Research and Development, AbbVie Inc., North Chicago, Illinois 60064, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Drug\rProduct Development, Research and Development, AbbVie Inc., North Chicago, Illinois 60064, United States","institution_ids":["https://openalex.org/I2948539688"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5101493659","display_name":"Yi Gao","orcid":"https://orcid.org/0000-0002-4347-0294","observed_orcids":["https://orcid.org/0000-0002-4347-0294"]},"institutions":[{"id":"https://openalex.org/I2948539688","display_name":"AbbVie (United States)","ror":"https://ror.org/02g5p4n58","country_code":"US","type":"company","lineage":["https://openalex.org/I2948539688"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Yi Gao","raw_affiliation_strings":["Drug\rProduct Development, Research and Development, AbbVie Inc., North Chicago, Illinois 60064, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Drug\rProduct Development, Research and Development, AbbVie Inc., North Chicago, Illinois 60064, United States","institution_ids":["https://openalex.org/I2948539688"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5090835640","display_name":"Lynne S. Taylor","orcid":"https://orcid.org/0000-0002-4568-6021","observed_orcids":["https://orcid.org/0000-0002-4568-6021"]},"institutions":[{"id":"https://openalex.org/I219193219","display_name":"Purdue University West Lafayette","ror":"https://ror.org/02dqehb95","country_code":"US","type":"education","lineage":["https://openalex.org/I219193219"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Lynne S. Taylor","raw_affiliation_strings":["Department\rof Industrial and Physical Pharmacy, College of Pharmacy, Purdue University, West Lafayette, Indiana 47907, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department\rof Industrial and Physical Pharmacy, College of Pharmacy, Purdue University, West Lafayette, Indiana 47907, United States","institution_ids":["https://openalex.org/I219193219"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":["https://openalex.org/A5090835640"],"corresponding_institution_ids":["https://openalex.org/I219193219"],"apc_list":{"value":4500,"currency":"USD","value_usd":4500},"apc_paid":null,"fwci":5.8517,"has_fulltext":false,"cited_by_count":63,"citation_normalized_percentile":{"value":0.97252178,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":89,"max":100},"biblio":{"volume":"11","issue":"10","first_page":"3565","last_page":"3576"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10256","display_name":"Drug Solubulity and Delivery Systems","score":0.9297000169754028,"subfield":{"id":"https://openalex.org/subfields/3003","display_name":"Pharmaceutical Science"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10256","display_name":"Drug Solubulity and Delivery Systems","score":0.9297000169754028,"subfield":{"id":"https://openalex.org/subfields/3003","display_name":"Pharmaceutical Science"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11881","display_name":"Crystallization and Solubility Studies","score":0.06800000369548798,"subfield":{"id":"https://openalex.org/subfields/2505","display_name":"Materials Chemistry"},"field":{"id":"https://openalex.org/fields/25","display_name":"Materials Science"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}},{"id":"https://openalex.org/T10389","display_name":"Polymer crystallization and properties","score":0.0005000000237487257,"subfield":{"id":"https://openalex.org/subfields/2507","display_name":"Polymers and Plastics"},"field":{"id":"https://openalex.org/fields/25","display_name":"Materials Science"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/amorphous-solid-dispersions","display_name":"amorphous solid dispersions","score":0.9879999756813049},{"id":"https://openalex.org/keywords/crystallization-kinetics","display_name":"crystallization kinetics","score":0.7540000081062317},{"id":"https://openalex.org/keywords/polymorphic-transition","display_name":"polymorphic transformation","score":0.7260000109672546},{"id":"https://openalex.org/keywords/polyvinylpyrrolidone","display_name":"polyvinylpyrrolidone","score":0.843999981880188},{"id":"https://openalex.org/keywords/hydroxypropyl-methylcellulose","display_name":"hydroxypropyl methylcellulose","score":0.9760000109672546},{"id":"https://openalex.org/keywords/matrix-crystallization","display_name":"matrix crystallization","score":0.7590000033378601},{"id":"https://openalex.org/keywords/multivariate-curve-resolution","display_name":"multivariate curve resolution","score":0.8450000286102295},{"id":"https://openalex.org/keywords/poorly-water-soluble-drugs","display_name":"poorly water-soluble drugs","score":0.7599999904632568},{"id":"https://openalex.org/keywords/drug-polymorphism","display_name":"drug polymorphism","score":0.3540000021457672}],"concepts":[{"id":"https://openalex.org/C203036418","wikidata":"https://www.wikidata.org/wiki/Q284256","display_name":"Crystallization","level":2,"score":0.8378622531890869},{"id":"https://openalex.org/C88380143","wikidata":"https://www.wikidata.org/wiki/Q416674","display_name":"Dissolution","level":2,"score":0.7955852150917053},{"id":"https://openalex.org/C56052488","wikidata":"https://www.wikidata.org/wiki/Q103382","display_name":"Amorphous solid","level":2,"score":0.7368943691253662},{"id":"https://openalex.org/C42360764","wikidata":"https://www.wikidata.org/wiki/Q83588","display_name":"Chemical engineering","level":1,"score":0.5789424777030945},{"id":"https://openalex.org/C192562407","wikidata":"https://www.wikidata.org/wiki/Q228736","display_name":"Materials science","level":0,"score":0.5445783734321594},{"id":"https://openalex.org/C2780077769","wikidata":"https://www.wikidata.org/wiki/Q413433","display_name":"Polyvinylpyrrolidone","level":2,"score":0.48865965008735657},{"id":"https://openalex.org/C155574463","wikidata":"https://www.wikidata.org/wiki/Q170731","display_name":"Solubility","level":2,"score":0.46683016419410706},{"id":"https://openalex.org/C122865956","wikidata":"https://www.wikidata.org/wiki/Q825643","display_name":"Glass transition","level":3,"score":0.4643106460571289},{"id":"https://openalex.org/C184651966","wikidata":"https://www.wikidata.org/wiki/Q906356","display_name":"Aqueous solution","level":2,"score":0.4202324450016022},{"id":"https://openalex.org/C521977710","wikidata":"https://www.wikidata.org/wiki/Q81163","display_name":"Polymer","level":2,"score":0.41956621408462524},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.30697667598724365},{"id":"https://openalex.org/C8010536","wikidata":"https://www.wikidata.org/wiki/Q160398","display_name":"Crystallography","level":1,"score":0.26075369119644165},{"id":"https://openalex.org/C178790620","wikidata":"https://www.wikidata.org/wiki/Q11351","display_name":"Organic chemistry","level":1,"score":0.24346694350242615},{"id":"https://openalex.org/C188027245","wikidata":"https://www.wikidata.org/wiki/Q750446","display_name":"Polymer chemistry","level":1,"score":0.18003079295158386},{"id":"https://openalex.org/C127413603","wikidata":"https://www.wikidata.org/wiki/Q11023","display_name":"Engineering","level":0,"score":0.0}],"mesh":[{"descriptor_ui":"D003460","descriptor_name":"Crystallization","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007700","descriptor_name":"Kinetics","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009543","descriptor_name":"Nifedipine","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":true},{"descriptor_ui":"D011108","descriptor_name":"Polymers","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":true},{"descriptor_ui":"D011205","descriptor_name":"Povidone","qualifier_ui":"Q000031","qualifier_name":"analogs & derivatives","is_major_topic":false},{"descriptor_ui":"D011205","descriptor_name":"Povidone","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":false},{"descriptor_ui":"D012995","descriptor_name":"Solubility","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D013059","descriptor_name":"Spectrum Analysis, Raman","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D044367","descriptor_name":"Phase Transition","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D065347","descriptor_name":"Hypromellose Derivatives","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.1021/mp500333v","doi":"https://doi.org/10.1021/mp500333v","is_oa":false,"landing_page_url":"https://doi.org/10.1021/mp500333v","pdf_url":null,"source":{"id":"https://openalex.org/S204562082","display_name":"Molecular Pharmaceutics","issn_l":"1543-8384","issn":["1543-8384","1543-8392"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-c","doyens","jufo-2","ki-jl-1","medline","norway-1","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320006","host_organization_name":"American Chemical Society","host_organization_lineage":["https://openalex.org/P4310320006"],"host_organization_lineage_names":["American Chemical Society"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Molecular Pharmaceutics","raw_type":"journal-article"},{"id":"pmid:25185035","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/25185035","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Molecular pharmaceutics","raw_type":"Journal Article"}],"best_oa_location":null,"sustainable_development_goals":[],"sustainable_development_goals_aurora":[{"id":"https://metadata.un.org/sdg/6","score":0.550000011920929,"display_name":"Clean water and sanitation"}],"study_designs":[],"awards":[],"funders":[{"id":"https://openalex.org/F4320308573","display_name":"Gilead Sciences","ror":"https://ror.org/056546b03"},{"id":"https://openalex.org/F4320309036","display_name":"Purdue University","ror":"https://ror.org/02dqehb95"},{"id":"https://openalex.org/F4320309117","display_name":"AbbVie","ror":"https://ror.org/02g5p4n58"}],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":61,"referenced_works":["https://openalex.org/W53851219","https://openalex.org/W130612557","https://openalex.org/W205849754","https://openalex.org/W1543696264","https://openalex.org/W1789419133","https://openalex.org/W1963847586","https://openalex.org/W1967935934","https://openalex.org/W1970379036","https://openalex.org/W1970767638","https://openalex.org/W1971847221","https://openalex.org/W1972843211","https://openalex.org/W1976021540","https://openalex.org/W1983225022","https://openalex.org/W1984021830","https://openalex.org/W1987497957","https://openalex.org/W1990663620","https://openalex.org/W1994190231","https://openalex.org/W1994461620","https://openalex.org/W1999392761","https://openalex.org/W2008667086","https://openalex.org/W2013841303","https://openalex.org/W2014956897","https://openalex.org/W2015211919","https://openalex.org/W2016049659","https://openalex.org/W2016579523","https://openalex.org/W2024664025","https://openalex.org/W2025965551","https://openalex.org/W2028704089","https://openalex.org/W2029074560","https://openalex.org/W2031862218","https://openalex.org/W2032268755","https://openalex.org/W2032688741","https://openalex.org/W2037352792","https://openalex.org/W2039141867","https://openalex.org/W2041574733","https://openalex.org/W2044594845","https://openalex.org/W2046032738","https://openalex.org/W2049439891","https://openalex.org/W2051055753","https://openalex.org/W2054420149","https://openalex.org/W2059365736","https://openalex.org/W2062309495","https://openalex.org/W2071853811","https://openalex.org/W2080825492","https://openalex.org/W2083147803","https://openalex.org/W2083604634","https://openalex.org/W2086483407","https://openalex.org/W2087713059","https://openalex.org/W2087898315","https://openalex.org/W2091980429","https://openalex.org/W2101212670","https://openalex.org/W2126130682","https://openalex.org/W2139893082","https://openalex.org/W2169796533","https://openalex.org/W2313432411","https://openalex.org/W2320765608","https://openalex.org/W2327742714","https://openalex.org/W2330536366","https://openalex.org/W2335512730","https://openalex.org/W3048125775","https://openalex.org/W4285719527"],"related_works":["https://openalex.org/W6979882839","https://openalex.org/W2004715275","https://openalex.org/W2169796533","https://openalex.org/W4320035311","https://openalex.org/W2039163843","https://openalex.org/W2009938495","https://openalex.org/W4403101201","https://openalex.org/W2616964979","https://openalex.org/W1989461604","https://openalex.org/W2053383323"],"abstract_inverted_index":{"The":[0],"commercial":[1],"and":[2,88,101,109,124,141],"clinical":[3],"success":[4],"of":[5,15,30,37,44,67,91,103,115,139,152,233],"amorphous":[6,45,81,173,187,203],"solid":[7,162,204],"dispersions":[8,205],"(ASD)":[9],"in":[10,78,98,159,194],"overcoming":[11],"the":[12,27,42,65,70,84,86,99,137,149,160,166,186,195,211,228],"low":[13],"bioavailability":[14],"poorly":[16],"soluble":[17],"molecules":[18],"has":[19],"generated":[20,169],"momentum":[21],"among":[22],"pharmaceutical":[23],"scientists":[24],"to":[25,47,51,63,135,147,177,182,219,226],"advance":[26],"fundamental":[28],"understanding":[29],"these":[31,38],"complex":[32,229],"systems.":[33],"A":[34,113],"major":[35],"limitation":[36],"formulations":[39],"stems":[40],"from":[41,165,185,210],"propensity":[43],"solids":[46],"crystallize":[48,183],"upon":[49],"exposure":[50],"aqueous":[52,178],"media.":[53],"This":[54],"study":[55],"was":[56,180,200,214,217],"specifically":[57],"focused":[58],"on":[59,69],"developing":[60],"analytical":[61,116],"techniques":[62,126],"evaluate":[64,136],"impact":[66],"polymers":[68,191],"crystallization":[71,87,140,156,199,209],"behavior":[72,232],"during":[73,170],"dissolution,":[74],"which":[75],"is":[76],"critical":[77],"designing":[79],"effective":[80],"formulations.":[82],"In":[83],"study,":[85],"polymorphic":[89,142],"conversions":[90],"a":[92],"model":[93],"compound,":[94],"nifedipine,":[95,174],"were":[96,133,192,206],"explored":[97],"absence":[100],"presence":[102],"polyvinylpyrrolidone":[104],"(PVP),":[105],"hydroxypropylmethyl":[106],"cellulose":[107],"(HPMC),":[108],"HPMC-acetate":[110],"succinate":[111],"(HPMC-AS).":[112],"combination":[114],"approaches":[117],"including":[118],"Raman":[119],"spectroscopy,":[120],"polarized":[121],"light":[122],"microscopy,":[123],"chemometric":[125],"such":[127],"as":[128,144,146],"multivariate":[129],"curve":[130],"resolution":[131],"(MCR)":[132],"used":[134],"kinetics":[138],"transitions":[143],"well":[145],"identify":[148],"primary":[150],"route":[151],"crystallization,":[153],"i.e.,":[154],"whether":[155],"took":[157],"place":[158],"dissolving":[161],"matrix":[163],"or":[164],"supersaturated":[167],"solutions":[168],"dissolution.":[171],"Pure":[172],"when":[175,190,202],"exposed":[176],"media,":[179],"found":[181,218],"rapidly":[184],"matrix,":[188],"even":[189],"present":[193],"dissolution":[196],"medium.":[197],"Matrix":[198],"avoided":[201],"prepared,":[207],"however,":[208],"solution":[212],"phase":[213,230],"rapid.":[215],"MCR":[216],"be":[220],"an":[221],"excellent":[222],"data":[223],"processing":[224],"technique":[225],"deconvolute":[227],"transition":[231],"nifedipine.":[234]},"counts_by_year":[{"year":2026,"cited_by_count":2},{"year":2025,"cited_by_count":5},{"year":2024,"cited_by_count":2},{"year":2023,"cited_by_count":1},{"year":2022,"cited_by_count":5},{"year":2021,"cited_by_count":5},{"year":2019,"cited_by_count":7},{"year":2018,"cited_by_count":5},{"year":2017,"cited_by_count":15},{"year":2016,"cited_by_count":9},{"year":2015,"cited_by_count":6},{"year":2014,"cited_by_count":1}],"updated_date":"2026-10-31T12:09:11.096373","created_date":"2016-06-24T00:00:00"}